For the quarter (end-April 1), the vendor had revenues of $768 million, up 7% from the $720 million reported in the second quarter of fiscal 2012. Varian had net earnings of $113 million, compared with $108 million a year ago.
For the six-month period, Varian's revenues were $1.4 billion, up 8% from the $1.3 billion reported in fiscal 2012. Net earnings were $208 million, compared with $198 million for the same period a year ago.
Revenues in the company's Oncology Systems unit were $582 million in the second quarter, up 3% from $565 million in 2012. Oncology Systems revenues were stable during the six-month period as compared to last year. For its X-Ray Products business, Varian posted revenues of $140 million for the second quarter of 2013, up 14% compared to $123 million for the same period last year. The unit's six-month revenues grew 15%, from $236 million in 2012 to $273 million in 2013.